Keppra and Keppra XR (levetiracetam) Briefing Materials
For the September 12, 2017 meeting of the FDA’s Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
Briefing Materials
- Keppra and Keppra XR Safety and Utilization Review
- Keppra Labeling, 4.2017
- Keppra XR Labeling, 4.2017
- Keppra and Keppra XR Division Director Review
- Keppra and Keppra XR Cross-Discipline Team Leader Review
- Keppra and Keppra XR Clinical Review
- Keppra and Keppra XR ClinPharm Review